General Information of the Compound
| Compound ID |
CP0853912
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4-((6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl)methyl)piperazin-1-yl)(pyrazin-2-yl)methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H23Cl2N7O
|
||||||||||||||||||
| Molecular Weight |
508.413
|
||||||||||||||||||
| Canonical SMILES |
O=C(c1cnccn1)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3cnc(C4CC4)cn23)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H23Cl2N7O/c26-17-3-4-18(19(27)11-17)24-22(34-14-21(16-1-2-16)30-13-23(34)31-24)15-32-7-9-33(10-8-32)25(35)20-12-28-5-6-29-20/h3-6,11-14,16H,1-2,7-10,15H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
NYLYLOYOHYFBQC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04657, Solute carrier family 2, facilitated glucose transporter member 1
Protein ID: PT06319, Solute carrier family 2, facilitated glucose transporter member 2
Protein ID: PT06387, Solute carrier family 2, facilitated glucose transporter member 3
Protein ID: PT03440, Solute carrier family 2, facilitated glucose transporter member 4